The Protein Kinase Double-Stranded RNA-Dependent (PKR) Enhances Protection against Disease Cause by a Non-Viral Pathogen

PLoS Pathogens

Volumn 9, Issue 8, 2013, Pages

  Ogolla, Pauline Sebby ^a   Portillo, Jose Andres C ^a   White, Christine L ^b   Patel, Krupen ^a   Lamb, Bruce ^b   Sen, Ganes C ^b   Subauste, Carlos S ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CD40 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 1; INTERLEUKIN 12; NITRIC OXIDE; PROTEIN KINASE R; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; TUMOR NECROSIS FACTORRECEPTOR ASSOCIATED FACTOR 2; UNCLASSIFIED DRUG; CYTOKINE; INDUCIBLE NITRIC OXIDE SYNTHASE; MAP1LC3 PROTEIN, MOUSE; MICROTUBULE ASSOCIATED PROTEIN; NOS2 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR;

ANIMAL CELL; ANIMAL TISSUE; ANTIMICROBIAL ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGY; CELL PROTECTION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENETIC TRANSFECTION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MACROPHAGE; MICROGLIA; MICROSCOPY; MOUSE; NONHUMAN; PARASITE LOAD; POLYMERASE CHAIN REACTION; PROTEIN PHOSPHORYLATION; TOXOPLASMOSIS; ANIMAL; ENZYMOLOGY; GENETICS; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TOXOPLASMA;

ANIMALS; ANTIGENS, CD40; AUTOPHAGY; CYTOKINES; EIF-2 KINASE; MACROPHAGES; MICE; MICE, KNOCKOUT; MICROGLIA; MICROTUBULE-ASSOCIATED PROTEINS; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TOXOPLASMA; TOXOPLASMOSIS; TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PEPTIDES AND PROTEINS;

EID: 84883347520     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003557     Document Type: Article

References (96)

1. Clemens MJ, (1997) PKR- A protein kinase regulated by double-stranded RNA. Am J Biochem Cell Biol 29: 945-949.
2. Williams BRG, (2001) Signal integration via PKR. Sci STKE 89: re2.
3. Garcia MA, Gil J, Ventoso I, Guerra S, Domingo E, et al. (2006) Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action. Microbiol Mol Biol Rev 70: 1032-1060.
4. Nanduri S, Carpick BW, Yang Y, Williams BR, Qin J, (1998) Structure of the double-stranded RNA-binding domain of the protein kinase PKR reveals the molecular basis of its dsRNA-mediated activation. EMBO J 17: 5458-5465.
5. Li S, Peters GA, Ding K, Zhang X, Qin J, et al. (2006) Molecular basis for PKR activation by PACT or dsRNA. Proc Natl Acad Sci USA 103: 10005-10010.
6. Balachandran S, Roberts PC, Brown LE, Truong H, Pattnaik AK, et al. (2000) Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. Immunity 13: 129-141.
7. Stojdl DF, Abraham N, Knowles S, Marius R, Brasey A, et al. (2000) The murine double-stranded RNA-dependent protein kinase PKR is required for resistance to vesicular stomatitis virus. J Virol 74: 9580-9585.
8. Nakayama Y, Plisch EH, Sullivan J, Thomas C, Czuprynski CJ, et al. (2010) Role of PKR and type I IFNs in viral control during primary and secondary infection. PLoS Pathogens pp. e1000966.
9. Carr DJJ, Wuest T, Tomanek L, Silverman RH, Williams BRG, (2006) The lack of RNA-dependent protein kinase enhances susceptibility of mice to genital herpes simples virus type 2 infection. Immunology 118: 520-526.
10. Kumar A, Yang Y-L, Flati V, Der S, Kadereit S, et al. (1997) Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: role of IRF-1 and NF-κB. EMBO J 16: 406-416.
11. Sharma B, Altman JK, Goussetis DJ, Verma AK, Platanias LC, (2011) Protein kinase R as mediator of the effects of interferon (IFN) γ and tumor necrosis factor (TNF) α on normal and dysplastic hematopoiesis. J Biol Chem 286: 27506-27514.
12. Garcia MA, Meurs EF, Esteban M, (2007) The dsRNA protein kinase PKR: virus and cell control. Biochemie 89: 799-811.
13. Goh KC, deVeer MJ, Williams BRG, (2000) The protein kinase PKR is required for p38 MAPK activation and the innate immune response to bacterial endotoxin. EMBO J 19: 4292-4297.
14. Mundschau LJ, Faller DV, (1995) Platelet-derived growth factor signal transduction through the interferon-inducible kinase PKR. Immediate early gene induction. J Biol Chem 270: 3100-3106.
15. Ito T, Yang M, May WS, (1999) RAX, a cellular activator for double-stranded RNA-dependent protein kinase during stress signaling. J Biol Chem 274: 15427-15432.
16. Patel RC, Sen GC, (1998) PACT, a protein activator of the interferon-induced protein kinase, PKR. EMBO J 17: 4379-4390.
17. Cabanski M, Steinmuller M, Marsh LM, Surdziel E, Seeger W, et al. (2008) PKR regulates TLR2/TLR4-dependent signaling in murine alveolar macrophages. Am J Respir Cell Mol Biol 38: 26-31.
18. Cheung BK, Lee DC, Li JC, Lau YL, Lau AS, (2005) A role for double-stranded RNA-activated protein kinase PKR in Mycobacterium-induced cytokine expression. J Immunol 175: 7218-7225.
19. Pereira RMS, Dias Teixeira KL, Barreto-de-Souza V, Calegari-Silva TC, De-Melo LDB, et al. (2010) Novel role for the double-stranded RNA-activated protein kinase PKR: modulation of macrophage infection by the protozoan parasite Leishmania. FASEB J 24: 617-626.
20. Wu KK, Koo J, Jiang X, Chen R, Cohen SN, et al. (2012) Improved control of tuberculosis and activation of macrophages in mice lacking protein kinase R. Plos One 7: e30512.
21. Mordue DG, Sibley LD, (1997) Intracellular fate of vacuoles containing Toxoplasma gondii is determined at the time of formation and depends on the mechanisms of entry. J Immunol 159: 4452-4459.
22. Suzuki Y, Remington JS, (1988) Dual regulation of resistance against Toxoplasma gondii infection by Lyt-2+ and Lyt-1+, L3T4+ T cells in mice. J Immunol 140: 3943-3946.
23. Gazzinelli R, Xu Y, Hieny S, Cheever A, Sher A, (1992) Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. J Immunol 149: 175-180.
24. Denkers EY, Gazzinelli RT, (1998) Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clin Microbiol Rev 11: 569-588.
25. Suzuki Y, Conley FK, Remington JS, (1989) Importance of endogenous IFN-γ for prevention of toxoplasmic encephalitis in mice. J Immunol 143: 2045-2050.
26. Gazzinelli RT, Eltoum I, Wynn TA, Sher A, (1993) Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-α and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation. J Immunol 151: 3672-3681.
27. Gazzinelli RT, Brezin A, Li Q, Nussenblatt RB, Chan CC, (1994) Toxoplasma gondii: acquired ocular toxoplasmosis in the murine model, protective role of TNF-α and IFN-γ. Exp Parasitol 78: 217-229.
28. Hayashi S, Chan C-C, Gazzinelli RT, Pham NTH, Cheung MK, et al. (1996) Protective role of nitric oxide in ocular toxoplasmosis. Br J Ophthalmol 80: 644-648.
29. Scharton-Kersten T, Yap G, Magram J, Sher A, (1997) Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii. J Exp Med 185: 1261-1273.
30. Yap GS, Scharton-Kersten T, Charest H, Sher A, (1998) Decreased resistance of TNF receptor p55- and p75-deficient mice to chronic toxoplasmosis despite normal activation of inducible nitric oxide synthase in vivo. J Immunol 160: 1340-1345.
31. Deckert-Schluter M, Bluethmann H, Rang A, Hof H, Schluter D, (1998) Crucial role of TNF receptor type 1 (p55), but not of TNF receptor type 2 (p75), in murine toxoplasmosis. J Immunol 160: 3427-3436.
32. Gilfoy FD, Mason PW, (2007) West Nile Virus-induced interferon production is mediated by the double-stranded RNA-dependent protein kinase PKR. J Virol 81: 11148-11158.
33. Chakrabarti A, Sadler AJ, Kar N, Young HA, Silverman RH, et al. (2008) Protein kinase R-dependent regulation of interleukin-10 in response to double-stranded RNA. J Biol Chem 282: 25132-25139.
34. Uetani K, Der SD, Zamanian-Daryoush M, de la Motte C, Lieberman BY, et al. (2000) Central role of double-stranded RNA-activated protein kinase in microbial induction of nitric oxide synthase. J Immunol 165: 988-996.
35. Suzuki Y, Orellana MA, Schreiber RD, Remington JS, (1988) Interferon-γ: the major mediator of resistance against Toxoplasma gondii. Science 240: 516-518.
36. Gazzinelli RT, Wysocka M, Hayashi S, Denkers EY, Hieny S, et al. (1994) Parasite-induced IL-12 stimulates early IFN-γ synthesis and resistance during acute infection with Toxoplasma gondii. J Immunol 153: 2533-2543.
37. Yap G, Pesin M, Sher A, (2000) IL-12 is required for the maintenance of IFN-γ production in T cells mediating chronic resistance to the intracellular pathogen, Toxoplasma gondii. J Immunol 165: 628-631.
38. Hunter CA, Abrams JS, Beaman MH, Remington JS, (1993) Cytokine mRNA in the central nervous system of SCID mice infected with Toxoplasma gondii: importance of T-cell-independent regulation of resistance to T. gondii. Infect Immun 61: 4033-4044.
39. Suzuki Y, Rani S, Liesenfeld O, Kojima T, Lim S, et al. (1997) Impaired resistance to the development of toxoplasmic encephalitis in interleukin-6-deficient mice. Infect Immun 65: 2339-2345.
40. Wilson EH, Wille-Reece U, Dzierszinski F, Hunter CA, (2005) A critical role for IL-10 in limiting inflammation during toxoplasmic encephalitis. J Neuroimmunol 165: 63-74.
41. Kirchhoff S, Koromilas AE, Schaper F, Grashoff M, Sonenberg N, et al. (1995) IRF-1 induced cell growth inhibition and interferon induction requires the activity of the protein kinase PKR. Oncogene 11: 439-445.
42. Lee SB, Esteban M, (1994) The interferon-inducced double-stranded RNA-activated protein kinase induces apoptosis. Virology 199: 491-496.
43. White CL, Whitmore MM, Williams BRG, (2007) Enlarged spleens without enlarged lymph nodes in tlr3-/- pkr-/- mice. J Interferon Cytokine Res 27: 6-12.
44. Jankovic D, Kullberg MC, Feng CG, Goldszmid RS, Collazo CM, et al. (2007) Conventional T-bet+Foxp3- Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J Exp Med 204: 273-283.
45. Thakur SA, Zalinger ZB, Johnson TR, Imani F, (2011) Protein kinase R is a novel mediator of CD40 signaling and plays a critical role in modulating immunoglobulin expression during respiratory syncytial virus infection. Clin Vaccine Immunol 18: 2060-2066.
46. Kang H, Remington JS, Suzuki Y, (2000) Decreased resistance of B cell-deficient mice to infection with Toxoplasma gondii despite unimpaired expression of IFN-γ, TNF-α, and inducible nitric oxide synthase. J Immunol 164: 2629-2643.
47. Deckert-Schluter M, Rang A, Weiner D, Huang S, Wiestler OD, et al. (1996) Interferon-γ receptor-deficiency renders mice highly susceptible to toxoplasmosis by decreased macrophage activation. Lab Invest 75: 827-841.
48. Deckert M, Sedgwick JD, Fischer E, Schluter D, (2006) Regulation of microglial cell responses in murine Toxoplasma encephalitis by CD200/CD200 receptor interaction. Acta Neuropathol 111: 548-558.
49. Reichmann G, Walker W, Villegas EN, Craig L, Cai G, et al. (2000) The CD40/CD40 ligand interaction is required for resistance to toxoplasmic encephalitis. Infect Immun 68: 1312-1318.
50. Portillo J-AC, Okenka G, Reed E, Subauste A, Van Grol J, et al. (2010) The CD40-autophagy pathway is needed for host protection despite IFN-γ-dependent immunity and CD40 induces autophagy via control of p21 levels. Plos One pp. e14472.
51. Andrade RM, Wessendarp M, Subauste CS, (2003) CD154 activates macrophage anti-microbial activity in the absence of IFN-γ through a TNF-α-dependent mechanism. J Immunol 171: 6750-6756.
52. Andrade RM, Wessendarp M, Portillo J-AC, Yang J-Q, Gomez FJ, et al. (2005) TRAF6 signaling downstream of CD40 primes macrophages to acquire anti-microbial activity in response to TNF-α. J Immunol 175: 6014-6021.
53. Andrade RM, Wessendarp M, Gubbels MJ, Striepen B, Subauste CS, (2006) CD40 induces macrophage anti-Toxoplasma gondii activity by triggering autophagy-dependent fusion of pathogen-containing vacuoles and lysosomes. J Clin Invest 116: 2366-2377.
54. Subauste CS, Andrade RM, Wessendarp M, (2007) CD40-TRAF6 and autophagy-dependent anti-microbial activity in macrophages. Autophagy 3: 245-248.
55. Chung JY, Park YC, Ye H, Wu H, (2002) All TRAFs are not created equal: common and distinct molecular mechanisms of TRAF-mediated signal transduction. J Cell Sci 115: 679-688.
56. Bishop GA, (2004) The multifaceted roles of TRAFs in the regulation of B-cell function. Nat Rev Immunol 4: 775-786.
57. Gil J, Garcia MA, Gomez-Puertas P, Guerra S, Rullas J, et al. (2004) TRAF family proteins link PKR with NF-kappa B activation. Mol Cell Biol 24: 4502-4512.
58. Pullen SS, Miller HG, Everdeen DS, Dang TT, Crute JJ, et al. (1998) CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization. Biochemistry 37: 11836-11845.
59. Davies CC, Mak TW, Young LS, Eliopoulos AG, (2005) TRAF6 is required for TRAF2-dependent CD40 signal transduction in nonhemopoietic cells. Mol Cel Biol 25: 9806-9819.
60. Mizushima N, Yoshimori T, Ohsumi Y, (2010) The role of Atg proteins in autophagosome formation. Annu Rev Cell Dev Biol 27: 107-132.
61. Kimura S, Noda T, Yoshimori T, (2007) Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3. Autophagy 3: 452-460.
62. Ben-Asouli Y, Banai Y, Pel-Or Y, Shir A, Kaempfer R, (2002) Human interferon-γ mRNA autoregulates its translation through a pseudoknot that activates the interferon-inducible protein kinase PKR. Cell 108: 221-232.
63. Suzuki Y, Conley FK, Remington JS, (1990) Treatment of toxoplasmic encephalitis in mice with recombinant gamma interferon. Infect Immun 58: 3050-3055.
64. Gazzinelli RT, Hakim FT, Hieny S, Shearer GM, Sher A, (1991) Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-γ production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. J Immunol 146: 286-292.
65. Denkers EY, Yap G, Scharton-Kersten T, Charest H, Butcher BA, et al. (1997) Perforin-mediated cytolysis plays a limited role in host resistance to Toxoplasma gondii. J Immunol 159: 1903-1908.
66. Subauste CS, Koniaris AH, Remington JS, (1991) Murine CD8+ cytotoxic T lymphocytes lyse Toxoplasma gondii-infected cells. J Immunol 147: 3955-3959.
67. Hakim FT, Gazzinelli RT, Denkers EY, Hieny S, Shearer GM, et al. (1991) CD8+ T cells from mice vaccinated against Toxoplasma gondii are cytotoxic for parasite-infected or antigen-pulsed host cells. J Immunol 147: 2310-2316.
68. Suzuki Y, Wang X, Jortner BS, Payne L, Ni Y, et al. (2010) Removal of Toxoplasma gondii cysts from the brain by perforin-mediated activity of CD8+ T cells. Am J Pathol 176: 1607-1613.
69. Deb A, Haque J, Morgesen T, Silverman RH, Williams BRG, (2001) RNA-dependent protein kinase PKR is required for activation of NF-κB by IFN-γ in a STAT1-independent pathway. J Immunol 166: 6170-6180.
70. Takada Y, Ichikawa HT, Pataer A, Swisher S, Aggarwal BB, (2007) Genetic deletion of PKR abrogates TNF-induced activation of IkBa kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation. Oncogene 26: 1201-1212.
71. Cheshire JL, Williams BRG, Baldwin AS, (1999) Involvement of double-stranded RNA-activated protein kinase in the synergistic activation of nuclear factor-κB by tumor necrosis factor-α and γ-interferon in preneural cells. J Biol Chem 274: 4801-4806.
72. Maggi LB, Heitmeier MR, Scheuner D, Kaufman RJ, Mark R, et al. (2000) Potential role of PKR in double-stranded RNA-induced macrophage activation. EMBO J 19: 3630-3636.
73. Diebold SS, Montoya M, Unger H, Alexopoulou L, Roy P, et al. (2003) Viral infection switches non-plasmacytoid dendritic cells into high interferon producers. Nature 424: 324-328.
74. Yap G, Ling YM, Zhao Y, (2007) Autophagic elimination of intracellular parasites. Convergent induction by IFN-γ and CD40 ligation? Autophagy 3: 163-165.
75. Kuwajima S, Sato T, Ishida K, Tada H, Tezuka H, et al. (2006) Interleukin 15-dependent crosstalk between conventional and plasmacytoid dendritic cells is essential for CpG-induced immune activation. Nat Immunol 7: 740-746.
76. Wang Y, Kelly CG, Karttunen JT, Whithall T, Lehner PJ, et al. (2001) CD40 is a cellular receptor mediating Mycobacterial heat shock protein 70 stimulation of C-C chemokines. Immunity 15: 971-983.
77. Weiss LM, Ma YF, Takvorian PM, Tanowitz HB, Wittner M, (1998) Bradyzoite development in Toxoplasma gondii and the hsp70 stress response. Infect Immun 66: 3295-3302.
78. Kiener PA, Moran-Davis P, Rankin BM, Wahl AF, Aruffo A, et al. (1995) Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes. J Immunol 155: 4917-4925.
79. Foster GR, Germain C, Jones M, Lechler RI, Lombardi G, (2000) Human T cells elicit IFN-α secretion from dendritic cells following cell to cell interactions. Eur J Immunol 30: 3228-3235.
80. Pullen SS, Dang TTA, Crute JJ, Kehry MR, (1999) CD40 signaling through Tumor Necrosis Factor Receptor-associated Factors (TRAFs). Binding site specificity and activation of down-stream pathways by distinct TRAFs. J Biol Chem 274: 14246-14254.
81. Pfaller CK, Li Z, George CX, Samuel CE, (2011) Protein kinase PKR and RNA adenosine deaminase ADAR1: new roles for old players as modulators of the interferon response. Curr Opin Immunol 23: 573-582.
82. Levine B, Mizushima N, Virgin HW, (2011) Autophagy in immunity and inflammation. Nature 469: 323-335.
83. Talloczy Z, Jiang W, Virgin HW, Leib DA, Scheuner D, et al. (2002) Regulation of starvation- and virus-induced autophagy by the eIF2α signaling pathway. Proc Natl Acad Sci USA 99: 190-195.
84. Talloczy Z, Virgin HW, Levine B, (2006) PKR-dependent autophagic degradation of herpes simplex virus type 1. Autophagy 2: 24-29.
85. Orvedahl A, Alexander D, Talloczy Z, Sun Q, Wei Y, et al. (2007) HSV-1 ICP34.5 confers neurovirulence by targeting the Beclin 1 autophagy protein. Cell Host & Microbe 1: 23-35.
86. Schluter D, Bertsch D, Frei K, Hubers SB, Wiestler OD, et al. (1998) Interferon-γ antagonizes transforming growth factor-β2-mediated immunosuppression in murine Toxoplasma encephalitis. J Neuroimmunol 81: 38-48.
87. Yang Y-L, Reis LFL, Pavlovic J, Aguzzi A, Schafer R, et al. (1995) Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J 14: 6095-6106.
88. Gubbels MJ, Li C, Striepen B, (2003) High-throughput growth assay for Toxoplasma gondii using yellow fluorescent protein. Antimicrob Agents Chemother 47: 309-316.
89. McKee AS, Dzierszinski F, Boes M, Roos DS, Pearce EJ, (2004) Functional inactivation of immature dendritic cells by the intracellular parasite Toxoplasma gondii. J Immunol 173: 2632-2640.
90. Johnson LL, Lanthier P, Hoffman J, Chen W, (2004) Vaccination protects B cell-deficient mice against an oral challenge with mildly virulent Toxoplasma gondii. Vaccine 22: 4054-4061.
91. Park E-M, Cho S, Frys K, Racchumi G, Zhou P, et al. (2004) Interaction between inducible nitric oxide synthase and poly(ADP-ribose) polymerase in focal ischemic brain injury. Stroke 35: 2896-2901.
92. Tomalka J, Ganesan S, Azodi E, Patel K, Majmundar P, et al. (2011) A novel role for the NLRC4 inflammasome in mucosal defenses against the fungal pathogen Candida albicans. PLoS Pathog 7: e1002379.
93. Overbergh L, Valckx D, Waer M, Mathieu C, (1999) Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR. Cytokine 11: 305-312.
94. Subauste CS, Subauste A, Wessendarp M, (2007) Role of CD40-dependent down-regulation of CD154 in impaired induction of CD154 in CD4+ T cells from HIV-1-infected patients. J Immunol 178: 1645-1653.
95. Andrade RM, Portillo J-AC, Wessendarp M, Subauste CS, (2005) CD40 signaling in macrophages induces anti-microbial activity against an intracellular pathogen independently of IFN-γ and reactive nitrogen intermediates. Infect Immun 73: 3115-3123.
96. Ben Mkaddem S, Pedruzzi E, Werts C, Coant N, Bens M, et al. (2010) Heat shock protein gp96 and NAD{sound recording copyright}H oxidase 4 play key roles in Toll-like receptor 4-activated apoptosis during renal ischemia/reperfusion injury. Cell Death and Differ 17: 1474-1485.